{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:15:00Z","timestamp":1791238500923,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Rates of obesity are rising in patients with inflammatory bowel disease [IBD]. We conducted a US population-based study to determine the effects of obesity on outcomes in hospitalised patients with IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched the Nationwide Readmissions Database 2016-2017 to identify all adult patients hospitalised for IBD, using ICD-10 codes. We compared obese (body mass index [BMI]\u2005\u2265\u200530) vs non-obese [BMI\u2005&amp;lt;\u200530] patients with IBD to evaluate the independent effects of obesity on readmission, mortality, and other hospital outcomes. Multivariate regression and propensity matching were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 143 190 patients with IBD, of whom 9.1% were obese. Obesity was independently associated with higher all-cause readmission at 30 days {18% vs 13% (adjusted odds ratio [aOR] 1.16, p\u2005=\u20050.005)} and 90 days (29% vs 21% [aOR 1.27, p\u2005&amp;lt;\u20050.0001]), as compared with non-obese patients, with similar findings upon a propensity-matched sensitivity analysis. Obese and non-obese patients had similar risks of mortality on index admission [0.24% vs 0.31%, p\u2005=\u20050.18] and readmission [1.5% vs 1.8% p\u2005=\u20050.3]. Obese patients had longer [5.3 vs 4.9 days] and more expensive [USD12,195 vs USD11,154] hospitalisations on index admission. Obesity did not affect the risk of intestinal surgery or bowel obstruction. Compared with index admissions, readmissions were characterised by increased mortality [6-fold], health care use, and bowel obstruction [3-fold] [all p\u2005&amp;lt;\u20050.0001].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Obesity in IBD appears to be associated with increased early readmission, characterised by a higher burden, despite the introduction of weight-based therapeutics. Prevention of obesity should be a focus in the treatment of IBD to decrease readmission and health care burden.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab088","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T20:14:40Z","timestamp":1620677680000},"page":"1807-1815","source":"Crossref","is-referenced-by-count":22,"title":["Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-6217","authenticated-orcid":false,"given":"Simcha","family":"Weissman","sequence":"first","affiliation":[{"name":"Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtenkumar","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, North Shore University Hospital, Conway, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhura","family":"Kolli","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lipcsey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Walfish","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, Elmhurst, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Swaminath","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Inflammatory Bowel Disease Program, Lenox Hill Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Feuerstein","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"2021110815400891000_CIT0001","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/MIB.0000000000000560","article-title":"Impact of obesity on the management and clinical course of patients with inflammatory bowel disease","volume":"21","author":"Seminerio","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0002","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","article-title":"The increasing weight of Crohn\u2019s disease subjects in clinical trials: a hypothesis-generating time-trend analysis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0003","article-title":"Rising rate of obesity in patients admitted for Crohn\u2019s disease increases costs but not mortality","author":"Lipcsey","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"2021110815400891000_CIT0004","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011\u20132014","volume":"219","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"key":"2021110815400891000_CIT0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"2021110815400891000_CIT0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021110815400891000_CIT0007","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021110815400891000_CIT0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"2021110815400891000_CIT0009","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10620-010-1541-6","article-title":"Is obesity a risk factor for Crohn\u2019s disease?","volume":"56","author":"Mendall","year":"2011","journal-title":"Dig Dis Sci"},{"key":"2021110815400891000_CIT0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MIB.0000000000000283","article-title":"Measures of obesity and risk of Crohn\u2019s disease and ulcerative colitis","volume":"21","author":"Khalili","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0011","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.12659\/MSM.901969","article-title":"The impact of obesity on the clinical course of inflammatory bowel disease: a meta-analysis","volume":"23","author":"Hu","year":"2017","journal-title":"Med Sci Monit"},{"key":"2021110815400891000_CIT0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.14309\/ajg.0000000000000197","article-title":"Impact of obesity on disease activity and Patient-Reported Outcomes Measurement Information System [PROMIS] in inflammatory bowel diseases","volume":"114","author":"Jain","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2021110815400891000_CIT0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ysur.2012.04.034","article-title":"Surgical site infections and cost in obese patients undergoing colorectal surgery","volume":"2012","author":"Pruett","year":"2012","journal-title":"Yearbook of Surgery"},{"key":"2021110815400891000_CIT0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cgh.2018.07.004","article-title":"Obesity is independently associated with higher annual burden and costs of hospitalisation in patients with inflammatory bowel diseases","volume":"17","author":"Nguyen","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021110815400891000_CIT0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"J Inflamm Res"},{"key":"2021110815400891000_CIT0016","article-title":"Role of hospital teaching status on outcomes of patients with inflammatory bowel disease: a nationwide analysis","author":"Sharma","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2021110815400891000_CIT0017","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-014-3174-7","article-title":"Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn\u2019s disease in the Veterans Affairs Health Care System","volume":"59","author":"Hou","year":"2014","journal-title":"Dig Dis Sci"},{"key":"2021110815400891000_CIT0018","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1155\/2015\/724359","article-title":"Characterization of inflammatory bowel disease in elderly hospitalised patients in a large central Canadian Health region","volume":"29","author":"Stepaniuk","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2021110815400891000_CIT0019","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged \u226518 years - United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021110815400891000_CIT0020","author":"World Health Organization"},{"key":"2021110815400891000_CIT0021","volume-title":"Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017\u20132018. NCHS Data Brief, no 360.","author":"Hales","year":"2020"},{"key":"2021110815400891000_CIT0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mjafi.2017.12.001","article-title":"Correlation of visceral body fat with waist-hip ratio, waist circumference and body mass index in healthy adults: a cross sectional study","volume":"76","author":"Gadekar","year":"2020","journal-title":"Med J Armed Forces India"},{"key":"2021110815400891000_CIT0023","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"2021110815400891000_CIT0024","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/biom9120780","article-title":"Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases","volume":"9","author":"Bilski","year":"2019","journal-title":"Biomolecules"},{"key":"2021110815400891000_CIT0025","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1007\/s10620-017-4806-5","article-title":"Association between adipokines levels with Inflammatory Bowel Disease [IBD]: systematic reviews","volume":"62","author":"Morshedzadeh","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2021110815400891000_CIT0026","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.3748\/wjg.v20.i22.6912","article-title":"Serum adipokines in inflammatory bowel disease","volume":"20","author":"Waluga","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2021110815400891000_CIT0027","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MCG.0000000000000356","article-title":"Dysbiosis: a review highlighting obesity and inflammatory bowel disease","volume":"49[Suppl 1]","author":"Kim","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"2021110815400891000_CIT0028","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fimmu.2013.00510","article-title":"Bacterial translocation\u2014impact on the adipocyte compartment","volume":"4","author":"Kruis","year":"2014","journal-title":"Front Immunol"},{"key":"2021110815400891000_CIT0029","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2021110815400891000_CIT0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.MIB.0000200345.38837.46","article-title":"Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease","volume":"12","author":"Karmiris","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nutres.2013.12.006","article-title":"A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans","volume":"34","author":"Berthon","year":"2014","journal-title":"Nutr Res"},{"key":"2021110815400891000_CIT0032","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/MIB.0000000000000537","article-title":"Risk factors for rehospitalisation within 90 days in patients with inflammatory bowel disease","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0033","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/MIB.0000000000001121","article-title":"Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database","volume":"23","author":"Barnes","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00384-014-2051-3","article-title":"The effect of body weight on the severity and clinical course of ulcerative colitis","volume":"30","author":"Stabroth-Akil","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"2021110815400891000_CIT0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jss.2018.04.037","article-title":"Risk factors for readmission following ileal pouch\u2013anal anastomosis: an American College of Surgeons National Surgical Quality Improvement Program analysis","volume":"229","author":"McKenna","year":"2018","journal-title":"J Surg Res"},{"key":"2021110815400891000_CIT0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cgh.2012.09.026","article-title":"Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010","volume":"11","author":"Jess","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021110815400891000_CIT0037","doi-asserted-by":"crossref","DOI":"10.1007\/s00384-021-03912-y","article-title":"Impact of inflammatory bowel disease on hospital outcomes in acute ischemic stroke: a nationwide cohort study","author":"Ghoneim","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"2021110815400891000_CIT0038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2020.12.017","article-title":"Predictors of venous thromboembolism in hospitalised patients with inflammatory bowel disease and colon cancer: a retrospective cohort study","volume":"199","author":"Achebe","year":"2021","journal-title":"Thromb Res"},{"key":"2021110815400891000_CIT0039","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/MIB.0000000000000173","article-title":"Inflammatory bowel disease cause-specific mortality: a primer for clinicians","volume":"20","author":"Kassam","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/atm.2017.03.107","article-title":"Morbidity and mortality associated with obesity","volume":"5","author":"Abdelaal","year":"2017","journal-title":"Ann Transl Med"},{"key":"2021110815400891000_CIT0041","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.14309\/00000434-201610001-00591","article-title":"Obesity is associated with worse outcomes in hospitalised patients with inflammatory bowel diseases: a nationwide study","volume":"111","author":"Singh","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2021110815400891000_CIT0042","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10620-020-06329-9","article-title":"A phenome-wide analysis of health care costs associated with inflammatory bowel diseases","volume":"66","author":"Cai","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2021110815400891000_CIT0043","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/ibd\/izy393.111","article-title":"Obesity is associated with greater economic burden on hospitalisations with inflammatory bowel disease","volume":"25","author":"Chakinala","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2021110815400891000_CIT0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/clnu.2001.0503","article-title":"Crohn\u2019s disease clinical course and severity in obese patients","volume":"21","author":"Blain","year":"2002","journal-title":"Clin Nutr"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab088\/38653800\/jjab088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/15\/11\/1807\/41107267\/jjab088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/15\/11\/1807\/41107267\/jjab088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T15:40:54Z","timestamp":1636386054000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/15\/11\/1807\/6276891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,5,17]]},"published-print":{"date-parts":[[2021,11,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab088","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,5,17]]}}}